Skip to navigation Skip to sub-navigation Skip to content

People

Sara Ricardez Hernandez

Ph.D. Candidate, Molecular Pathogenesis and Therapeutics

ricardezhernandezs@mail.missouri.edu
404 Bond Life Sciences Center

News about Sara Ricardez Hernandez

2019

Targeting tauopathy with engineered tau-degrading intrabodies. Gallardo G, Wong CH, Ricardez SM, Mann CN, Lin KH, Leyns CEG, Jiang H, Holtzman DM. Molecular Neurodegeneration; 14(1):38.

Date published: October 22, 2019
Featured in this article: Sara Ricardez Hernandez.

Go to article...